ADAP Advocacy has released a policy paper calling for common sense reforms in the 340B Drug Pricing Program. The lack of accountability and transparency, particularly among large hospital systems, is compared to the financial market collapse in 2007-08. The program's explosive growth raises concerns, and bold action is needed to prevent its failure, as it is a vital part of the healthcare system.